Sales & Marketing News | pharmaphorum

News

Telehealth firm fraud charges may worsen ADHD drug shortage

Two executives at a telehealth start-up have been arrested and are facing allegations of fraud involving the distribution of medicines for attention-deficit hyperactivity disorder (ADHD).

News

Radiopharma firm Telix abandons Nasdaq listing plans

Just days after Telix priced a $200 million initial public offering (IPO) in the US, the Australian radiopharmaceutical specialist has abandoned the plan.

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

News

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be f

News

GSK et al file appeal to Delaware Zantac order

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead.

News

EU orders bird flu vaccine supplies from CSL Seqirus

CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine to the European Commission as part of the EU’s efforts to prepare for a potential outbreak of the disease, with a

Telehealth firm fraud charges may worsen ADHD drug shortage

Radiopharma firm Telix abandons Nasdaq listing plans

FDA widens label for BMS’ cancer drug Augtyro

WuXi buoyed as BIOSECURE Act is left out of US spending bill

GSK et al file appeal to Delaware Zantac order

EU orders bird flu vaccine supplies from CSL Seqirus

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks